Home About us Contact
|
Home About us Contact | ||
|
|
||
Recurrent Primary Biliary Cirrhosis (recurrent + primary_biliary_cirrhosis)
Selected AbstractsRecurrent Primary Biliary Cirrhosis After Liver TransplantationAMERICAN JOURNAL OF TRANSPLANTATION, Issue 4 2010M. G. Silveira Recurrent primary biliary cirrhosis (PBC) is an important clinical outcome after liver transplantation (LT) in selected patients. Prevalence rates for recurrent PBC (rPBC) reported by individual LT programs range between 9% and 35%. The diagnostic hallmark of rPBC is histologic identification of granulomatous changes. Clinical and biochemical features are frequently absent with rPBC and cannot be used alone for diagnostic purposes. Some of the risk factors of rPBC may include recipient factors such as age, gender, HLA status and immunosuppression, as well as donor factors such as age, gender and ischemic time, although controversy exists. Most patients have early stage disease at the time of diagnosis, and there may be a role for therapy with ursodeoxycholic acid. While short- and medium-term outcomes remain favorable, especially if compared to patients transplanted for other indications, continued follow-up may identify reduced long-term graft and patient survival. [source] Recurrent primary biliary cirrhosisLIVER TRANSPLANTATION, Issue 6 2003James Neuberger Liver transplantation remains the only effective treatment for end-stage primary biliary cirrhosis (PBC). It appears now well accepted that the disease recurs in the allograft. The diagnosis of recurrent PBC is made on the basis of a consistent history and demonstrating the histologic features of PBC on liver biopsy and exclusion of other causes of bile duct damage [source] Recurrent Primary Biliary Cirrhosis After Liver TransplantationAMERICAN JOURNAL OF TRANSPLANTATION, Issue 4 2010M. G. Silveira Recurrent primary biliary cirrhosis (PBC) is an important clinical outcome after liver transplantation (LT) in selected patients. Prevalence rates for recurrent PBC (rPBC) reported by individual LT programs range between 9% and 35%. The diagnostic hallmark of rPBC is histologic identification of granulomatous changes. Clinical and biochemical features are frequently absent with rPBC and cannot be used alone for diagnostic purposes. Some of the risk factors of rPBC may include recipient factors such as age, gender, HLA status and immunosuppression, as well as donor factors such as age, gender and ischemic time, although controversy exists. Most patients have early stage disease at the time of diagnosis, and there may be a role for therapy with ursodeoxycholic acid. While short- and medium-term outcomes remain favorable, especially if compared to patients transplanted for other indications, continued follow-up may identify reduced long-term graft and patient survival. [source] New insights from recurrent primary biliary cirrhosis in liver transplantation: The paradox of BEComing a fibroblast?,,HEPATOLOGY, Issue 4 2007Shawn Wasilenko Ph.D. No abstact. [source] | ||||||||||